(Hypertension. 1996;28:1047-1054.)
© 1996 American Heart Association, Inc.
Articles |
Hypertension in Obese Zucker Rats
Role of Angiotensin II and Adrenergic Activity
the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson.
We designed our studies to determine whether blood pressure is elevated in obese Zucker rats compared with lean control rats and to test the importance of the renin-angiotensin and adrenergic nervous systems in long-term blood pressure control in this genetic model of obesity. We monitored mean arterial pressure 24 hours per day using computerized methods in 13- to 14-week-old lean and obese Zucker rats maintained on a fixed, normal sodium intake (3.3 mmol/d). Mean arterial pressure (average of 5 days) was higher in obese (100±1 mm Hg) than in lean (86±1) rats. Although control plasma renin activity was lower in obese than in lean rats (3.66±0.15 versus 5.48±0.11 ng angiotensin I/mL per hour), blood pressure sensitivity to exogenous angiotensin II was greater in obese than in lean rats. Blockade of endogenous angiotensin II receptors with losartan (10 mg/kg per day) for 7 days also caused a greater decrease in blood pressure in obese (36±2 mm Hg, n=6) than in lean (25±1, n=5) rats. However, combined 
- and ß-adrenergic blockade with terazosin (10 mg/kg per day) and propranolol (10 mg/kg per day), respectively, for 8 days caused only modest decreases in blood pressure in obese (9±3 mm Hg, n=8) and lean (4±2, n=6) rats, despite effective - and ß-adrenergic blockade. These results suggest that increased arterial pressure in obese Zucker rats depends in part on angiotensin II. However, additional mechanisms may also contribute to increased blood pressure in obese Zucker rats.
Key Words: obesity • blood pressure • renin • sympathetic nervous system • kidney • sodium
This article has been cited by other articles:
 |
|
 |
|
  A. H. Siddiqui, Q. Ali, and T. Hussain Protective Role of Angiotensin II Subtype 2 Receptor in Blood Pressure Increase in Obese Zucker Rats Hypertension, February 1, 2009; 53(2): 256 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. K. Madala Halagappa, S. Tiwari, S. Riazi, X. Hu, and C. M. Ecelbarger Chronic candesartan alters expression and activity of NKCC2, NCC, and ENaC in the obese Zucker rat Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1222 - F1231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-D. Lee, W.-W. Kuo, D.-T. Bau, F.-Y. Ko, F.-L. Wu, C.-H. Kuo, F.-J. Tsai, P. S. Wang, M.-C. Lu, and C.-Y. Huang The coexistence of nocturnal sustained hypoxia and obesity additively increases cardiac apoptosis J Appl Physiol, April 1, 2008; 104(4): 1144 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. C. Kopp, M. Z. Cicha, and M. A. Yorek Impaired responsiveness of renal sensory nerves in streptozotocin-treated rats and obese Zucker diabetic fatty rats: role of angiotensin Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R858 - R866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tiwari, V. K.M. Halagappa, S. Riazi, X. Hu, and C. A. Ecelbarger Reduced Expression of Insulin Receptors in the Kidneys of Insulin-Resistant Rats J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2661 - 2671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Stepp, E. I. Boesen, J. C. Sullivan, J. D. Mintz, C. D. Hair, and D. M. Pollock Obesity augments vasoconstrictor reactivity to angiotensin II in the renal circulation of the Zucker rat Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2537 - H2542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Siddiqui and T. Hussain Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1722 - H1727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zanchi, C. Perregaux, M. Maillard, D. Cefai, J. Nussberger, and M. Burnier The PPAR{gamma} agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1228 - E1234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Riazi, O. Khan, X. Hu, and C. A. Ecelbarger Aldosterone infusion with high-NaCl diet increases blood pressure in obese but not lean Zucker rats Am J Physiol Renal Physiol, September 1, 2006; 291(3): F597 - F605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ruggeri, A. Brunori, C. E. Cogo, D. Storace, F. Di Nardo, and R. Burattini Enhanced sympathetic reactivity associates with insulin resistance in the young Zucker rat Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R376 - R382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Hakam and T. Hussain Angiotensin II Type 2 Receptor Agonist Directly Inhibits Proximal Tubule Sodium Pump Activity in Obese But Not in Lean Zucker Rats Hypertension, June 1, 2006; 47(6): 1117 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Frisbee Impaired hemorrhage tolerance in the obese Zucker rat model of metabolic syndrome J Appl Physiol, February 1, 2006; 100(2): 465 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Hakam, A. H. Siddiqui, and T. Hussain Renal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats Am J Physiol Renal Physiol, February 1, 2006; 290(2): F503 - F508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. da Silva, J. J. Kuo, L. S. Tallam, J. Liu, and J. E. Hall Does Obesity Induce Resistance to the Long-Term Cardiovascular and Metabolic Actions of Melanocortin 3/4 Receptor Activation? Hypertension, February 1, 2006; 47(2): 259 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Naik, L. Xiang, and R. L. Hester Enhanced role for RhoA-associated kinase in adrenergic-mediated vasoconstriction in gracilis arteries from obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R154 - R161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Ahmed, N. D.L. Fisher, R. Stevanovic, and N. K. Hollenberg Body Mass Index and Angiotensin-Dependent Control of the Renal Circulation in Healthy Humans Hypertension, December 1, 2005; 46(6): 1316 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Khan, S. Riazi, X. Hu, J. Song, J. B. Wade, and C. A. Ecelbarger Regulation of the renal thiazide-sensitive Na-Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone Am J Physiol Renal Physiol, August 1, 2005; 289(2): F442 - F450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Banday, A. Marwaha, L. S. Tallam, and M. F. Lokhandwala Tempol Reduces Oxidative Stress, Improves Insulin Sensitivity, Decreases Renal Dopamine D1 Receptor Hyperphosphorylation, and Restores D1 Receptor-G-Protein Coupling and Function in Obese Zucker Rats Diabetes, July 1, 2005; 54(7): 2219 - 2226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Banday, A. H. Siddiqui, M. M. Menezes, and T. Hussain Insulin treatment enhances AT1 receptor function in OK cells Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1213 - F1219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Harte, P. McTernan, R. Chetty, S. Coppack, J. Katz, S. Smith, and S. Kumar Insulin-Mediated Upregulation of the Renin Angiotensin System in Human Subcutaneous Adipocytes Is Reduced by Rosiglitazone Circulation, April 19, 2005; 111(15): 1954 - 1961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Hakam and T. Hussain Renal Angiotensin II Type-2 Receptors Are Upregulated and Mediate the Candesartan-Induced Natriuresis/Diuresis in Obese Zucker Rats Hypertension, February 1, 2005; 45(2): 270 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Schreihofer, C. D. Hair, and D. W. Stepp Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R253 - R261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nielsen, J. R. Halliwill, M. J. Joyner, and M. D. Jensen Vascular Response to Angiotensin II in Upper Body Obesity Hypertension, October 1, 2004; 44(4): 435 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Banday, T. Hussain, and M. F. Lokhandwala Renal dopamine D1 receptor dysfunction is acquired and not inherited in obese Zucker rats Am J Physiol Renal Physiol, July 1, 2004; 287(1): F109 - F116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Sharma Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension? Hypertension, July 1, 2004; 44(1): 12 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. da Silva, J. J. Kuo, L. S. Tallam, and J. E. Hall Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension Hypertension, February 1, 2004; 43(2): 383 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hu, D. Zhang, L. Swenson, G. Chakrabarti, E. D. Abel, and S. E. Litwin Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1261 - H1269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Mattsson, M. Lai, J. Noble, E. McKinney, J. L. Yau, J. R. Seckl, and B. R. Walker Obese Zucker Rats Have Reduced Mineralocorticoid Receptor and 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression in Hippocampus--Implications for Dysregulation of the Hypothalamic-Pituitary-Adrenal Axis in Obesity Endocrinology, July 1, 2003; 144(7): 2997 - 3003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Coatmellec-Taglioni, J.-P. Dausse, Y. Giudicelli, and C. Ribiere Sexual Dimorphism in Cafeteria Diet-Induced Hypertension Is Associated with Gender-Related Difference in Renal Leptin Receptor Down-Regulation J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 362 - 367. [Abstract] [Full Text]
|
|
|
|
|
|
D. N. Umrani, A. A. Banday, T. Hussain, and M. F. Lokhandwala Rosiglitazone Treatment Restores Renal Dopamine Receptor Function in Obese Zucker Rats Hypertension, December 1, 2002; 40(6): 880 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shiuchi, T.-X. Cui, L. Wu, H. Nakagami, Y. Takeda-Matsubara, M. Iwai, and M. Horiuchi ACE Inhibitor Improves Insulin Resistance in Diabetic Mouse Via Bradykinin and NO Hypertension, September 1, 2002; 40(3): 329 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Fitzgerald, J. R. Henegar, M. W. Brands, L. K. Henegar, and J. E. Hall Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R547 - R552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Overton, T. D. Williams, J. B. Chambers, and M. E. Rashotte Cardiovascular and metabolic responses to fasting and thermoneutrality are conserved in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1007 - R1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M Sharma and S. Engeli The renin-angiotensin system in obesity hypertension Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S114 - S119. [PDF]
|
|
|
|
|
|
S. Engeli, R. Negrel, and A. M. Sharma Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin System Hypertension, June 1, 2000; 35(6): 1270 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Masuo, H. Mikami, T. Ogihara, and M. L. Tuck Weight Gain-Induced Blood Pressure Elevation Hypertension, May 1, 2000; 35(5): 1135 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Dobrian, M. J. Davies, R. L. Prewitt, and T. J. Lauterio Development of Hypertension in a Rat Model of Diet-Induced Obesity Hypertension, April 1, 2000; 35(4): 1009 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Carlson, J. Shelton, C. R. White, and J. M. Wyss Elevated Sympathetic Activity Contributes to Hypertension and Salt Sensitivity in Diabetic Obese Zucker Rats Hypertension, January 1, 2000; 35(1): 403 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hussain, S. A. Beheray, and M. F. Lokhandwala Defective Dopamine Receptor Function in Proximal Tubules of Obese Zucker Rats Hypertension, November 1, 1999; 34(5): 1091 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Karlsson, K. Lindell, M. Ottosson, L. Sjöström, B. Carlsson, and L. M. S. Carlsson Human Adipose Tissue Expresses Angiotensinogen and Enzymes Required for Its Conversion to Angiotensin II J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3925 - 3929. [Abstract] [Full Text]
|
|